A Randomized Phase II Study of VTX-2337 in Combination with Pegylated Liposomal Doxorubicin (PLD) vs PLD alone in the Treatment of Recurrent or Persi

Project: Research project

Status	Finished
Effective start/end date	12/1/15 → 11/30/16